• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ARX

AROA BIOSURGERY LIMITED - Corporate Spotlight

0.82% ! 61.5¢
Market Cap $212.1M  !

Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures,... Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from the ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that serve as the building blocks for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, Symphony, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM designed for soft tissue repair, reinforcement, and complex wounds.More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
61.5¢
Change
0.005(0.82%)
Mkt cap ! $212.1M
Open High Low Value Volume
60.5¢ 62.0¢ 60.5¢ $34.81K 56.86K

Buyers (Bids)

No. Vol. Price($)
2 7000 60.0¢
 

Sellers (Offers)

Price($) Vol. No.
62.5¢ 75000 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
ARX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.